Watch CBS News

Drug maker Eli Lilly says GLP-1 pill shows large success in clinical trial

Name: Drug maker Eli Lilly says GLP-1 pill shows large success in clinical trial
Uploaded: 2025-04-17T17:28:00-0400
Duration: 49 s
Description: Eli Lilly, which makes Zepbound and Mounjaro, reports that in a phase one clinical trial, a once daily GLP-1 pill helped lower the hemoglobin A1C, a measure of blood sugar control, in people with type 2 diabetes.

Eli Lilly, which makes Zepbound and Mounjaro, reports that in a phase one clinical trial, a once daily GLP-1 pill helped lower the hemoglobin A1C, a measure of blood sugar control, in people with type 2 diabetes.